Ac-Aib-Pro-Aib-Ala-Aib-Aib-Gln-Aib-Leu-Aib-Gly-Aib-Aib-Pro-Val-Aib-Aib-Gln-Gln-Leu-ol
| Internal ID | 7f0ba86f-1e42-4a29-9fb3-e5d1804e000f |
| Taxonomy | Organic Polymers > Polypeptides |
| IUPAC Name | (2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-[[(2S)-1-[2-[[2-[[2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[2-[[2-[[(2S)-2-[[2-[[(2S)-1-(2-acetamido-2-methylpropanoyl)pyrrolidine-2-carbonyl]amino]-2-methylpropanoyl]amino]propanoyl]amino]-2-methylpropanoyl]amino]-2-methylpropanoyl]amino]-5-amino-5-oxopentanoyl]amino]-2-methylpropanoyl]amino]-4-methylpentanoyl]amino]-2-methylpropanoyl]amino]acetyl]amino]-2-methylpropanoyl]amino]-2-methylpropanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-2-methylpropanoyl]amino]-2-methylpropanoyl]amino]-5-amino-5-oxopentanoyl]amino]-N-[(2S)-1-hydroxy-4-methylpentan-2-yl]pentanediamide |
| SMILES (Canonical) | CC(C)CC(CO)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)N)NC(=O)C(C)(C)NC(=O)C(C)(C)NC(=O)C(C(C)C)NC(=O)C1CCCN1C(=O)C(C)(C)NC(=O)C(C)(C)NC(=O)CNC(=O)C(C)(C)NC(=O)C(CC(C)C)NC(=O)C(C)(C)NC(=O)C(CCC(=O)N)NC(=O)C(C)(C)NC(=O)C(C)(C)NC(=O)C(C)NC(=O)C(C)(C)NC(=O)C2CCCN2C(=O)C(C)(C)NC(=O)C |
| SMILES (Isomeric) | C[C@@H](C(=O)NC(C)(C)C(=O)NC(C)(C)C(=O)N[C@@H](CCC(=O)N)C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)NCC(=O)NC(C)(C)C(=O)NC(C)(C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NC(C)(C)C(=O)NC(C)(C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)CO)NC(=O)C(C)(C)NC(=O)[C@@H]2CCCN2C(=O)C(C)(C)NC(=O)C |
| InChI | InChI=1S/C89H153N23O24/c1-45(2)41-50(44-113)95-63(120)51(33-36-57(90)115)96-64(121)52(34-37-58(91)116)97-73(130)83(15,16)109-77(134)87(23,24)107-69(126)61(47(5)6)100-67(124)55-31-29-39-111(55)79(136)89(27,28)110-75(132)85(19,20)102-60(118)43-93-70(127)80(9,10)105-66(123)54(42-46(3)4)99-72(129)82(13,14)104-65(122)53(35-38-59(92)117)98-74(131)84(17,18)108-76(133)86(21,22)103-62(119)48(7)94-71(128)81(11,12)106-68(125)56-32-30-40-112(56)78(135)88(25,26)101-49(8)114/h45-48,50-56,61,113H,29-44H2,1-28H3,(H2,90,115)(H2,91,116)(H2,92,117)(H,93,127)(H,94,128)(H,95,120)(H,96,121)(H,97,130)(H,98,131)(H,99,129)(H,100,124)(H,101,114)(H,102,118)(H,103,119)(H,104,122)(H,105,123)(H,106,125)(H,107,126)(H,108,133)(H,109,134)(H,110,132)/t48-,50-,51-,52-,53-,54-,55-,56-,61-/m0/s1 |
| InChI Key | KHUSJDWGFDJJCN-HGEPYVCOSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C89H153N23O24 |
| Molecular Weight | 1929.30 g/mol |
| Exact Mass | 1928.14588284 g/mol |
| Topological Polar Surface Area (TPSA) | 714.00 Ų |
| XlogP | -3.30 |
| Atomic LogP (AlogP) | -5.00 |
| H-Bond Acceptor | 24 |
| H-Bond Donor | 22 |
| Rotatable Bonds | 52 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.6144 | 61.44% |
| Caco-2 | - | 0.8580 | 85.80% |
| Blood Brain Barrier | - | 0.5750 | 57.50% |
| Human oral bioavailability | - | 0.5857 | 58.57% |
| Subcellular localzation | Lysosomes | 0.6374 | 63.74% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8570 | 85.70% |
| OATP1B3 inhibitior | + | 0.9412 | 94.12% |
| MATE1 inhibitior | - | 0.9412 | 94.12% |
| OCT2 inhibitior | - | 0.9250 | 92.50% |
| BSEP inhibitior | + | 0.9600 | 96.00% |
| P-glycoprotein inhibitior | + | 0.7421 | 74.21% |
| P-glycoprotein substrate | + | 0.8673 | 86.73% |
| CYP3A4 substrate | + | 0.7322 | 73.22% |
| CYP2C9 substrate | - | 0.7929 | 79.29% |
| CYP2D6 substrate | - | 0.8494 | 84.94% |
| CYP3A4 inhibition | - | 0.6116 | 61.16% |
| CYP2C9 inhibition | - | 0.9034 | 90.34% |
| CYP2C19 inhibition | - | 0.7625 | 76.25% |
| CYP2D6 inhibition | - | 0.8963 | 89.63% |
| CYP1A2 inhibition | - | 0.9125 | 91.25% |
| CYP2C8 inhibition | + | 0.6165 | 61.65% |
| CYP inhibitory promiscuity | - | 0.9797 | 97.97% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.7600 | 76.00% |
| Carcinogenicity (trinary) | Non-required | 0.5978 | 59.78% |
| Eye corrosion | - | 0.9793 | 97.93% |
| Eye irritation | - | 0.8954 | 89.54% |
| Skin irritation | - | 0.7802 | 78.02% |
| Skin corrosion | - | 0.8767 | 87.67% |
| Ames mutagenesis | - | 0.6900 | 69.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6983 | 69.83% |
| Micronuclear | + | 0.5800 | 58.00% |
| Hepatotoxicity | + | 0.5407 | 54.07% |
| skin sensitisation | - | 0.8785 | 87.85% |
| Respiratory toxicity | + | 0.7667 | 76.67% |
| Reproductive toxicity | + | 0.8000 | 80.00% |
| Mitochondrial toxicity | + | 0.6750 | 67.50% |
| Nephrotoxicity | - | 0.5881 | 58.81% |
| Acute Oral Toxicity (c) | III | 0.6610 | 66.10% |
| Estrogen receptor binding | - | 0.5569 | 55.69% |
| Androgen receptor binding | + | 0.7605 | 76.05% |
| Thyroid receptor binding | + | 0.7655 | 76.55% |
| Glucocorticoid receptor binding | + | 0.8278 | 82.78% |
| Aromatase binding | + | 0.8088 | 80.88% |
| PPAR gamma | + | 0.8012 | 80.12% |
| Honey bee toxicity | - | 0.7557 | 75.57% |
| Biodegradation | - | 0.8750 | 87.50% |
| Crustacea aquatic toxicity | + | 0.5324 | 53.24% |
| Fish aquatic toxicity | - | 0.7505 | 75.05% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.72% | 98.95% |
| CHEMBL3837 | P07711 | Cathepsin L | 99.62% | 96.61% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 98.77% | 98.33% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 98.58% | 98.94% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 98.33% | 94.45% |
| CHEMBL2730 | P21980 | Protein-glutamine gamma-glutamyltransferase | 97.94% | 92.38% |
| CHEMBL1914 | P06276 | Butyrylcholinesterase | 97.70% | 95.00% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.69% | 96.09% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 97.37% | 93.56% |
| CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 96.44% | 99.77% |
| CHEMBL2815 | P04629 | Nerve growth factor receptor Trk-A | 95.99% | 87.16% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 95.85% | 98.05% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 95.80% | 97.25% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 95.80% | 96.47% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 95.74% | 98.24% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 95.56% | 97.09% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 95.55% | 94.66% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 95.47% | 91.19% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 95.31% | 96.67% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 95.10% | 98.10% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 94.96% | 100.00% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 94.64% | 96.31% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 94.47% | 94.00% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 94.30% | 96.03% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 93.97% | 95.71% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 93.93% | 95.17% |
| CHEMBL2073 | P07947 | Tyrosine-protein kinase YES | 93.85% | 83.14% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 93.75% | 95.38% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 93.60% | 98.89% |
| CHEMBL321 | P14780 | Matrix metalloproteinase 9 | 93.52% | 92.12% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 93.33% | 100.00% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 93.17% | 96.28% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 92.96% | 100.00% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 92.95% | 97.14% |
| CHEMBL236 | P41143 | Delta opioid receptor | 92.94% | 99.35% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 92.14% | 83.10% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 91.90% | 96.67% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 91.20% | 97.64% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 91.01% | 97.50% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 90.97% | 82.69% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 90.77% | 88.42% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 90.47% | 97.43% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 90.33% | 91.11% |
| CHEMBL4005 | P42336 | PI3-kinase p110-alpha subunit | 90.13% | 97.47% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 89.95% | 90.08% |
| CHEMBL3018 | Q9Y5Y6 | Matriptase | 89.15% | 98.33% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 88.64% | 93.00% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 88.62% | 94.45% |
| CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 88.57% | 93.33% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 87.70% | 94.33% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 87.63% | 97.29% |
| CHEMBL283 | P08254 | Matrix metalloproteinase 3 | 87.54% | 97.29% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 87.34% | 99.17% |
| CHEMBL344 | Q99705 | Melanin-concentrating hormone receptor 1 | 87.30% | 92.50% |
| CHEMBL206 | P03372 | Estrogen receptor alpha | 87.04% | 97.64% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 86.87% | 97.50% |
| CHEMBL2534 | O15530 | 3-phosphoinositide dependent protein kinase-1 | 86.68% | 95.36% |
| CHEMBL1841 | P06241 | Tyrosine-protein kinase FYN | 86.53% | 81.29% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 86.49% | 100.00% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 86.46% | 96.90% |
| CHEMBL3105 | P09874 | Poly [ADP-ribose] polymerase-1 | 86.22% | 93.90% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 86.16% | 93.10% |
| CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 86.13% | 98.75% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 86.13% | 96.33% |
| CHEMBL274 | P51681 | C-C chemokine receptor type 5 | 85.80% | 98.77% |
| CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 85.49% | 96.25% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 85.34% | 96.00% |
| CHEMBL2140 | P48775 | Tryptophan 2,3-dioxygenase | 85.24% | 98.46% |
| CHEMBL249 | P25103 | Neurokinin 1 receptor | 84.42% | 99.17% |
| CHEMBL2664 | P23526 | Adenosylhomocysteinase | 84.23% | 86.67% |
| CHEMBL2095164 | P49354 | Geranylgeranyl transferase type I | 84.01% | 92.80% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 83.86% | 97.23% |
| CHEMBL3238 | P23786 | Carnitine palmitoyltransferase 2 | 83.59% | 94.05% |
| CHEMBL4660 | P28907 | Lymphocyte differentiation antigen CD38 | 83.53% | 95.27% |
| CHEMBL4801 | P29466 | Caspase-1 | 83.46% | 96.85% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 83.08% | 89.63% |
| CHEMBL5701 | Q9H2K8 | Serine/threonine-protein kinase TAO3 | 82.56% | 96.67% |
| CHEMBL5261 | Q7L7X3 | Serine/threonine-protein kinase TAO1 | 82.49% | 89.33% |
| CHEMBL5600 | P27448 | Serine/threonine-protein kinase c-TAK1 | 82.44% | 88.81% |
| CHEMBL2474 | P53582 | Methionine aminopeptidase 1 | 82.37% | 97.09% |
| CHEMBL2007625 | O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | 82.33% | 99.00% |
| CHEMBL5028 | O14672 | ADAM10 | 82.26% | 97.50% |
| CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 82.26% | 92.86% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 82.25% | 90.71% |
| CHEMBL3234 | P08631 | Tyrosine-protein kinase HCK | 82.06% | 88.89% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 81.98% | 95.00% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 81.55% | 92.88% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 81.27% | 95.83% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 80.85% | 95.89% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 80.66% | 95.50% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 80.63% | 96.11% |
| CHEMBL225 | P28335 | Serotonin 2c (5-HT2c) receptor | 80.14% | 89.62% |
| CHEMBL4330 | Q9NS75 | Cysteinyl leukotriene receptor 2 | 80.08% | 98.00% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 101290466 |
| LOTUS | LTS0123510 |
| wikiData | Q105141341 |